Abstract
Metastatic bone disease (MBD) commonly heralds the final progression of many cancers. Skeletal-related events (SRE) represent symptomatic bone metastases and usually present as pain, fracture, spinal cord compression, and hypercalcemia of malignancy. As patients with advanced disease live longer due to therapeutic advances, the number of patients with metastatic bone disease is increasing. The optimal management of MBD and SRE requires a coordinated team effort including specialists from surgical and nonsurgical disciplines. MBD management is far from a one-size-fits-all approach. Each patient must be evaluated within the context of their expectations and disease status. An appreciation of the underlying tumor biology combined with life expectancy estimates helps guide appropriate treatment. This article attempts to provide a framework in which to evaluate and treat patients with metastatic bone disease. In addition, an ask is made for orthopedic surgeons to develop an awareness for the need of an integrated multidisciplinary approach and consider assuming the lead role of the musculoskeletal team.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
